-
Sector | Healthcare |
---|---|
Industry | Drug Manufacturers - Specialty & Generic |
Exchange | HK |
CurrencyCode | HKD |
ISIN | KYG1090B1077 |
PE Ratio | 10.65 |
---|---|
Beta | 0.25 |
Market Cap | 2B |
Target Price | 2.42 |
Dividend Yield | 5.1% |
JBM (Healthcare) Limited, an investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally. It operates through Branded Medicines, Proprietary Chinese Medicines, and Health and Wellness Products segments. The Branded Medicines segment develops, manufactures, and distributes branded medicines with chemical compounds as active ingredients. The Proprietary Chinese Medicines segment develops, manufactures, and distributes registered Chinese medicines composed of Chinese herbal medicines. The Health and Wellness Products segment distributes and sells supplements, medical consumables, and other non-pharmaceutical products for the general health and wellness of consumers. The company also offers consumer healthcare and proprietary Chinese medicines, such as over-the-counter medicines, and medicated and non-medicated solutions, as well as diagnostic devices. It is also involved in the trading, wholesaling, and retailing of Chinese medicines; trading of medical supplies and pharmaceutical products; and sale of healthcare and herbal products. The company was incorporated in 2020 and is headquartered in Kwun Tong, Hong Kong.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 2161.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025